The Finding of No Significant Impact makes assumptions that are not warranted from past experience.
For instance;"the approval would only
allow AQUADVANTAGE Salmon to be produced and grown-out in the physically contained
freshwater culture facilities specified in the sponsor’s NADA."
Experience with drugs (which is the bizarre category applied here) shows extensive "off label" use as a routine occurence with no intervention or oversight by agencies.
"physically contained facilities" do not have a good track record. In the US, Grass Carp originated from physically contained facilities, and Aqua Bounty has a record of negligence in the 'escape' of Aquavantage salmon from their facility in Panama.
These fish will get out if permitted.
A FONSI is not warranted under these circumstances.
Jeremy K. Brown - Comment
This is comment on Notice
Environmental Assessments; Availability, etc.: Genetically Engineered Atlantic Salmon
View Comment
Related Comments
View AllPublic Submission Posted: 01/04/2013 ID: FDA-2011-N-0899-0053
Feb 25,2013 11:59 PM ET
Public Submission Posted: 01/04/2013 ID: FDA-2011-N-0899-0043
Feb 25,2013 11:59 PM ET
Public Submission Posted: 01/04/2013 ID: FDA-2011-N-0899-0044
Feb 25,2013 11:59 PM ET
Public Submission Posted: 12/31/2012 ID: FDA-2011-N-0899-0036
Feb 25,2013 11:59 PM ET
Public Submission Posted: 01/04/2013 ID: FDA-2011-N-0899-0051
Feb 25,2013 11:59 PM ET